Clinical trials
Phase 2/3 Atrial Fibrillation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2008 | 2 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ARYx Therapeutics | 1 |
| Boston Scientific Corporation | 1 |
| Intermountain Health Care, Inc. | 1 |
| Mayo Clinic | 1 |
| Sanofi | 1 |
| Stony Brook University | 1 |
| Vanderbilt University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 7 |
| Atrial Flutter | 2 |
| Arrhythmias, Cardiac | 1 |
| Cardiomyopathies | 1 |
| Ischemic Attack, Transient | 1 |
| Myocardial Infarction | 1 |
| Pulmonary Embolism | 1 |
| Stroke | 1 |
| Thromboembolism | 1 |
| Venous Thrombosis | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.